Lugli Lab
@luglilab
Immunology lab interested in memory T cell differentiation, adoptive cell transfer and cancer immunotherapy. Tweets by Enrico
ID:1150310364548149250
https://www.humanitas-research.org/groups/enrico-lugli-group/ 14-07-2019 07:45:37
1,2K Tweets
2,1K Followers
447 Following
Our review “CD4+ Regulatory T Cells in Human Cancer: Subsets, Origin, and Molecular Regulation” is out Cancer Immunology Research aacrjournals.org/cancerimmunolr…. We discuss Treg heterogeneity in cancer with focus on CCR8+ Tregs Cancer Research Institute
I’ll present Stanford Medicine next Mon 18 hosted by Bendall Lab. Stop by if you want to hear about immunometabolism in cancer and discuss some T cell stuff
med.stanford.edu/pathology/even…
Incredible talk by Gabriel Nunez today Humanitas Milano on host microbiota interaction and development of colitis
Interested in how the liver’s unique characteristics shape priming and maintenance of adaptive immunity? Check out our latest review now online in Annual Review of Immunology annualreviews.org/doi/abs/10.114…. Spearheaded by Keigo Kawashima, Francesco Andreata and Cristian Beccaria.
I has the pleasure to host Maxim Artyomov yesterday Humanitas Milano for a fantastic talk on T cell differentiation in aging
It was a pleasure to play a small part on this nice study by Sebastien Jaillon Cancer Immunology Research
This week: Dr. Sarah Whiteside and a team in the Roychoudhuri Lab found that CD4+ conventional #Tcells acquire suppressive functions upon #Treg depletion, limiting the efficacy of Treg-targeted therapies
📝 Science Immunology: bit.ly/3GVkCnO
🎧: bit.ly/3SlDqTU
Immunology Podcast Sarah Whiteside Roychoudhuri Lab Science Immunology Super insightful work that blurs the lines between friend and foe in our immune system!
📢Thrilled to share our latest research on #nextgeneration #anticancer #vaccines against T cell-depleted #tumours ! This helped discover a novel immunoresistance pathway mediated by PD-L1+ #macrophages in #mouse & #patients ! OncoAlert OncoDaily 1/11🧵
cell.com/cell-reports-m…
Supernice paper on cis-targeted IL-2 therapy for chronic HBV from Iannacone Lab Science Translational Medicine!